Introduction
Jaundice is a common problem occurring in 60% term babies during 1 st few days of life. 1 Most cases are benign, resolve spontaneously requiring medical intervention in 20% cases to treat significant jaundice. 2 Significant jaundice is found in 10.5% of term and 25.3% of late preterm infants. 3, 4 Therefore each case must be evaluated to detect at risk babies and follow up should be continued even after discharge from hospital as bilirubin level may vary over time and may not peak until 5 th day of life or later to prevent significant morbidity. 2 The gold standard for measurement of billirubin level in newborn is total serum billirubin estimation (TSB). 5, 6 In most postnatal ward the decision to perform TSB depends on postnatal age and visual assessment of jaundice using "Kramer Rule". 7 But poor correlation between visual assessment and total serum bilirubin was found in various study. 8, 9 Depending on visual assessment unnecessary blood tests are being practiced in newborn babies who do not have significant jaundice. Moreover, blood test is a painful, time-consuming and also stressful procedure for neonates and their parents. There was a constant search to find out comfortable and valid tool for detecting jaundice level in newborn.
Transcutaneous Billirubinometry offers a more objective method of assessing the degree of jaundice, reducing the subjectivity of clinical assessment. 9 It is also a safe, noninvasive, painless, technically easy, instantaneous reporting tool. 10 It is also an important 'Point of Care' test (bed side test) can be performed by doctor, nurse even others health staff in hospital as well as in community. 11 A number of previous studies showed a good correlation between transcutaneous and total serum billirubin measurement in term babies. [12] [13] [14] Accuracy of transcutanuous bilirubinometry is not widely accepted in preterm newborn. 15, 16 In preterm infant transcutaneous bilirubinometry is less accurate than in term infant as result are affected by immature skin and by different albumin to bilirubin binding. [16] [17] [18] In our country transcutaneous bilirubinometry has not been widely adopted due to concern of its validity and accuracy. In this context this study was performed with the objectives of estimating the relationship between transcutaneous bilirubin (TcB) and TSB and to evaluate whether transcutaneous billirubinometry could be a valid screening method for detecting jaundice in term and near term newborn.
Materials and Methods
A prospective cross-sectional study was conducted at well baby nursery of United Hospital in Dhaka from January to December, 2013. Total 116 healthy term and late preterm (>35 to <37 weeks) babies were enrolled. Jaundice was assessed in the newborn babies from 25 hours to 168 hours of postnatal life (due to most of the physiological jaundice appears 2 nd day onwards persists up to 5 to 7 days). We excluded sick baby requiring intensive care and who had major congenital anomalies and prior administration of phototherapy and Rh incompatibility. TCB and TSB correlation was done as primary outcome. Birth weight, gestational age, sex, postnatal age requirement of phototherapy and ABO incompatibility (initial inclusion of O+ve mother and A/B+ve baby was selected as normal physiological jaundice) were compared as secondary measures. Informed consent was taken from parents before enrollment.
A database was maintained to record birth details and to identify neonates born ≥35 wks of gestation. Gestation was determined by 1 st trimester USG (when available) or date of last menstrual period confirmed by Expanded New Ballard score within 24 hr. The identified neonates were assessed every 12 hrly for onset and progression of jaundice by an experienced pediatrician according to" Kramer's description" and decision for blood sampling was done according to clinical judgment and AAP guide line. 7, 15 The serum sample (1ml) was collected by venepuncture and serum bilirubin estimation in laboratory was done by Dichlorophenyl Diazonium method (cbas integra 700; hert ford shire, UK). 19 Phototherapy was started on TSB value according to AAP guideline2004. 15 This study performed TcB measurement using JM-103 within 30 min of serum sampling. For each newborn TcB readings was obtained by placing the device over forehead and sternum by trained nurses. A total of 3 readings were obtained from each infant and were averaged to obtain a single TcB value that was used in subsequent analysis. Only one device, JM-103 transcutaneous bilirubinometer was used for the whole study. JM-103 determines the yellowness (bilirubin) of the subcutaneous tissue of a neonate by measuring the difference in the optical densities of reflected light at 450 and 550 nm by the newborn skin. With this method, 2 optical paths are incorporated into a measuring probe that minimizes the interference due to melanin or skin maturity. When the light returns to the fiber, it is scattered from shallow areas of subcutaneous tissue and passes through the inner core (short optical path) of the fiber, where as the light scattered from deep areas of subcutaneous tissue pass through the outer core (long optical path). The reflected light is then collected by photodiodes. 3, 17 Based on the reflected wave specification, the cutaneous bilirubin is calculated. Data were entered and analyzed using SPSS (version 15). Relationship between TcB and TSB was determined using Pearson correlation coefficient. In order to assess agreement a Bland-Altman graph was constructed. Paired t test was performed for continuous variables and ANOVA test for repeated measures. P value of <0.05 was taken as statistically significant. Sensitivity and Specificity of our study cohort were calculated to find out the accuracy of TcB in place of TSB. The study protocol was approved by the hospital ethics committee.
Result
A total of 116 neonates were enrolled in study who meet the inclusion criteria. Among them 8 data were excluded due to technical error. Finally 108 data were analyzed and found strong correlation of TcB with TSB correlation coefficient 0.8, mean difference 0.83 and 95% CI 0.6 to 1.06. Regarding demographic variables (table-I), 57% were female, 43% were male. Term babies were 86% and 14% were late preterm. Gestational age varied 36 weeks to 40 weeks and mean gestational age 37.6±1.14. Weight of babies ranged from 2400 gm to 4000 gm and mean BW 3067±358 gm. Jaundice was This study demonstrated significant correlation between TcB and TSB (correlation coefficient 0.8, mean difference 0.83 and 95% CI 0.6 to 1.06). The correlation coefficient in our study is comparable to those obtained by Rubal telli et al ( r-0.89),R Ebbsen (r-0.88) R, Robertson et al (r-0.93) R and Janjiondamai et al (r-0.95). 17,18,20.21 The mean difference between the two measurements was statistically significant which prevent the use of TcB as a replacement for TSB. Ebbeson et al also found similar finding in their study. 18 The factors that interfere were accuracy of TcB are sex, gestational age, postnatal age, birth weight, haematocrit value, requirements of phototherapy . 22 This study result showed TcB is not affected by birth weight, gestational age, and sex. Similar finding is observed in Rubal et al 17 As we know skin maturation increases with post natal age, we found post natal age of our studied babies had significant relationship with TCB value. Similar findings was observed in Maria el al 14 and Luca et al 24 in contrast, Knupfer et al 25 and Baiee et al 28 did not find any relation of post natal age with TCB and TSB. The potential effect of post natal age is attributed to maturation and thickening skin and changed in the amount of albumin binding. These factors are exaggerated in preterm newborn, data from Ebbeson et al 18 support this. Karen et al 30 , Steven et al 31 found a direct linear relationship with greater birth weight and significant jaundice, which is in contrast to our study. Karen & Steven explained the relationship of higher birth weight to hyperbilirubinemia might be due to maternal diabetes, neonatal polycyhtemia, bruise and cephal hematoma of their babies. 30, 31 Overall 30% of our studies babies required phototherapy and phototherapy had significant relationship with TCB & STB (p value <.0001). So optimum TCB cut of value is applicable to capture significant jaundiced newborn who required phototherapy. The relationship of TCB and requirement of phototherapy was not found in the study done by Mansouri et al. 32 But Tan and Dong et al 33 found a relationship of TCB and requirement of phototherapy. 33 To identify as an effective screening tool TCB must have a high sensitivity and a desirable specificity. This study assessed sensitivity and specificity of TCB at different TCB cut-off values. it was found that at TCB cut-off 11mg/dl can detect TSB 13mg/dl with a sensitivity of 90% and specificity of 71%. Above this level blood test would be necessary to take appropriate therapeutic measures for starting phototherapy. This cut off value was lower than that of Maria et al 5 (cutoff value 14mg/dl, Nem-yun boo et al 14 (14. 6mg/dl) and Hemmati (15mg/dl). The cut of value were different probably they used different device.
This study had some limitations. High pressure liquid chromatography (HPLC) is a gold standard of billirubin estimation but we used DIAZO method in our study. Finally, we assessed only 116 babies and better result could be obtained by future studies with larger sample size.
Conclusion
Transcutaneous billirubinometry is a non-invasive and valid screening tool for assessing jaundice in newborn.
Recommendation
Though the device is expensive, it is long lasting, portable and provides instant result. It can be used in community level where blood sampling is difficult. So, it is very time to think about cost-benefit ratio of this tool.
